Immunobiology and treatment of cutaneous T-cell lymphoma
RR Goel, AH Rook - Expert Review of Clinical Immunology, 2024 - Taylor & Francis
Introduction Primary cutaneous T cell lymphomas (CTCL) are a heterogenous group of non-
Hodgkin lymphomas derived from skin-homing T cells. These include mycosis fungoides …
Hodgkin lymphomas derived from skin-homing T cells. These include mycosis fungoides …
Advances in the pharmacological management of cutaneous T-cell lymphoma
G Roccuzzo, A Roggo, E Ramelyte… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Current treatment guidelines for cutaneous T cell lymphoma (CTCL) advocate a
stage-driven approach, considering clinical presentation, symptom burden, and patient …
stage-driven approach, considering clinical presentation, symptom burden, and patient …
Cutaneous T-cell Lymphoma
DM Weiner, AH Rook - Hematology/Oncology Clinics, 2024 - hemonc.theclinics.com
Cutaneous T-cell lymphoma (CTCL) is a group of non-Hodgkin T-cell lymphomas that by
definition develop in and affect the skin but can potentially spread to other organs. There are …
definition develop in and affect the skin but can potentially spread to other organs. There are …
Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports
A Bernardelli, C Visco - Therapeutic Advances in …, 2025 - journals.sagepub.com
This report describes the cases of two patients with mycosis fungoides and Sézary
syndrome (MF/SS) who achieved clinical benefit with mogamulizumab combination …
syndrome (MF/SS) who achieved clinical benefit with mogamulizumab combination …